68 related articles for article (PubMed ID: 8072312)
21. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
22. [Surgical management of supraglottic laryngeal carcinoma in 182 patients with special emphasis on functional preservation].
Zhang L; Luan X; Pan X; Xie G; Xu F; Liu D; Lei D
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):59-61. PubMed ID: 11977641
[TBL] [Abstract][Full Text] [Related]
23. [Neck relapse-related factors of cN0 stage supraglottic cancer].
Yu WB; Zeng ZY; Chen FJ; Zhang Q
Ai Zheng; 2006 Mar; 25(3):355-8. PubMed ID: 16536994
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of HLA DR expression and lymphocytic infiltrate in laryngeal cancer including clinical and morphological correlations.
Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
Gen Diagn Pathol; 1998 Apr; 143(5-6):297-303. PubMed ID: 9653911
[TBL] [Abstract][Full Text] [Related]
25. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.
Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV
Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716
[TBL] [Abstract][Full Text] [Related]
26. [HLA typing in high risk keratoplasty].
Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
[TBL] [Abstract][Full Text] [Related]
27. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
28. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
29. CO2 laser treatment of supraglottic cancer.
Motta G; Esposito E; Testa D; Iovine R; Motta S
Head Neck; 2004 May; 26(5):442-6. PubMed ID: 15122661
[TBL] [Abstract][Full Text] [Related]
30. Are there common human leucocyte antigen associations in juvenile idiopathic arthritis and periodontitis?
Reichert S; Stein J; Fuchs C; John V; Schaller HG; Machulla HK
J Clin Periodontol; 2007 Jun; 34(6):492-8. PubMed ID: 17509091
[TBL] [Abstract][Full Text] [Related]
31. HLA class I and II antigens expression in patients with renal cell carcinoma.
Ozgur BC; Gonenc F; Yazicioglu AH
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225
[TBL] [Abstract][Full Text] [Related]
32. Relationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAIDs hypersensitivity.
Pacor ML; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Pradella P; Uxa L; Di Fede G; Rini G; Corrocher R
Mediators Inflamm; 2006; 2006(5):62489. PubMed ID: 17392574
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR antigens in patients with pulmonary tuberculosis in northern Poland. Preliminary report.
Dubaniewicz A
Arch Immunol Ther Exp (Warsz); 2000; 48(1):47-50. PubMed ID: 10722232
[TBL] [Abstract][Full Text] [Related]
34. Management of cancer of the supraglottis.
Scola B; Fernández-Vega M; Martínez T; Fernández-Vega S; Ramirez C
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):195-8. PubMed ID: 11226956
[TBL] [Abstract][Full Text] [Related]
35. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
[TBL] [Abstract][Full Text] [Related]
36. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
37. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of 57 patients with poorly differentiated carcinomas of the supraglottic larynx].
Liu WS; Tang PZ; Qi YF; Xu ZG; Li ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):562-5. PubMed ID: 15606009
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy for laryngeal cancer in patients under 50 years old.
Shimizu W; Ogino T; Ebihara S; Ikeda H
Jpn J Clin Oncol; 1995 Dec; 25(6):258-60. PubMed ID: 8523822
[TBL] [Abstract][Full Text] [Related]
40. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
